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ABSTRACT
Ser10 and Lys13 found near the active site tyrosine
of Escherichia coli DNA topoisomerase I are
conserved among the type IA topoisomerases.
Site-directed mutagenesis of these two residues to
AlareducedtherelaxationandDNAcleavageactivity,
with a more severe effect from the Lys13 mutation.
Changing Ser10 to Thr or Lys13 to Arg also resulted
in loss of DNA cleavage and relaxation activity of
the enzyme. In simulations of the open form of the
topoisomerase–DNA complex, Lys13 interacts dir-
ectly with Glu9 (proposed to be important in the
catalytic mechanism). This interaction is removed
in the K13A mutant, suggesting the importance of
lysine as either a proton donor or a stabilizing cation
during strandcleavage,while theLystoArg mutation
significantly distorts catalytic residues. Ser10 forms
a direct hydrogen bond with a phosphate group near
the active site and is involved in direct binding of
the DNA substrate; this interaction is disturbed in
the S10A and S10T mutants. This combination of a
lysine and a serine residue conserved in the active
site of type IA topoisomerases may be required for
correct positioning of the scissile phosphate and
coordination of catalytic residues relative to each
other so that DNA cleavage and subsequent strand
passage can take place.
INTRODUCTION
Topoisomerases are enzymes that couple the cleavage of
either a single- or double-strand of DNA with DNA strand
passage through the break before religation of DNA phos-
phodiester linkage, thus catalyzing the interconversions of
DNA topoisomers. Escherichia coli DNA topoisomerase I
is a well-studied example of the type IA family of DNA
topoisomerases which break a single strand of DNA in its
mechanism (1,2). Its major physiological role is the removal
of excessive negative supercoiling from chromosomal DNA
(3–5). It is encoded by the topA gene for a protein of 97 kDa
(6). The ﬁrst step of its mechanism of action is the non-
covalent binding of a single strand of DNA at its active
site. Tyr319 then acts as a nucleophile to attack a scissile
phosphate on the phosphodiester backbone bound at the active
site, and is covalently linked via its side chain to the 50-
phosphate of the cleaved DNA in the covalent intermediate
(7). The 30 oxygen on the scissile phosphate is the leaving
group. The enzyme then has to undergo conformational
change to allow passage of the complementary DNA strand
through the break to take place before the displaced 30-
hydroxyl group of the cleaved DNA acts as a nucleophile
to attack the phosphotyrosine linkage in the religation step
of the reaction. The linking number of DNA increases by
one as a result of each cycle of enzyme action.
The crystal structure of the N-terminal 67 kDa transesteri-
ﬁcation domain of this enzyme has been reported (8). Potential
catalytic roles for a number of conserved residues found near
the active site tyrosine have been explored in previous studies
by site-directed mutagenesis. Glu9 appears to be required for
DNA cleavage (9,10), and there is evidence for the acidic triad
of Asp111, Asp113 and Glu115 being involved in Mg(II)
binding (8,11). Glu9, Asp111 and Asp113 are residues con-
served in the Toprim catalytic domain found in type IA and II
topoisomerases, as well as other DnaG-type primases and
OLD family nucleases and may have common functions in
these different nucleotidyl transfer mechanisms (12). A role
for the positively charged side chain of Arg321 in stabilization
of the phenolate anion during nucleophilic attack has also been
proposed (9,13). His365 has been proposed to participate
in DNA binding and stabilize the orientation of active site
residues (14). The potential catalytic roles of other residues
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E.coli DNA topoisomerase III also belongs to the type IA
family of DNA topoisomerases and has high degree of
homology to E.coli topoisomerase I (15). When compared
with E.coli topoisomerase I, it has a much weaker relaxation
activity but a potent decatenating activity (16). The crystal
structure of a complex formed by a mutant form (active site
Tyr328 converted to Phe) of E.coli topoisomerase III and
single-stranded DNA (ssDNA) has been determined (17); in
addition, the structure of a different catalytically active mutant
(H365R) form of the E.coli topoisomerase I 67 kDa
transesteriﬁcation domain bound to ssDNA has been reported
(18) (Figure 1). In the topo III-DNA structure, Lys8 (topo III)
has been found to be in a position to interact with the phos-
phate group of the scissile bond, so a conserved functional role
was suggested for this residue. Examination of the sequence
homology of bacterial and archeal topoisomerase I, as well as
reverse gyrases showed that the N-terminal region between
Leu5 and Lys13 is highly conserved (Figure 2). Besides the
Glu9 residue previously determined to be important for DNA
cleavage (9,10), a combination of a serine and a lysine at
positions corresponding to Ser10 and Lys13 of E.coli
topoisomerase I represent residues with side chains that
could have potential catalytic functions. For bacterial topoi-
somerase III sequences, the conserved combination of lysine
and serine corresponds to Lys8 and Ser10 of E.coli
topoisomerase III. To examine the potential catalytic roles
of the conserved lysine and serine found at the active site
of type IA topoisomerases, site-directed mutagenesis was
carried out to convert Ser10 and Lys13 of E.coli
topoisomerase I to alanines, as well as Ser10 to Thr and
Lys13 to Arg. The mutant enzymes were puriﬁed to
homogeneity and characterized for the relaxation of negative
supercoils, as well the ability to carry out each of the indi-
vidual steps of interactions with DNA in the overall enzyme
mechanism.
MATERIALS AND METHODS
Topoisomerase preparations
Wild-type recombisnant E.coli topoisomerase I was expressed
and puriﬁed to >95% homogeneity by combination of phos-
phocellulose, hydroxylapitite and ssDNA agarose column
Figure 1. Structures of E.coli topoisomerase I and topoisomerase III. (A) Active site of topoisomerase I–ssDNA complex. (B) Active site of topoisomerase
III–ssDNAcomplex.Residueswithin10softheDNAsubstrateareshown;onlyresiduesdiscussedinthetextarelabeled.ThestructureoftopoisomeraseI[1MW8
(18)]andtopoisomeraseIII[1I7D(17)]weresuperimposedusingthebackboneofcomparablesecondarystructureelementsandareshownfromthesameorientation.
ThessDNAsubstrateisshowninorange.Theinsetsshowthestructureoftheentireenzyme;theactivesiteandbindingregionishighlighted.The2ntatthe30 endof
the topoisomerase III DNA strand have been omitted for clarity.
Glu9Ser10Lys13 NCBI ID
EcTopA MGKALVIVESPAKAKTINKYLGSDY 415338
HiTopA MSKSLVIVESPAKAKTINKYLGSQY 1205601
AaTopA     MELFIVESPTKAKTIQKFLGKGF 6226245
TmTopA     MSKKVKKYIVVESPAKARTIKSILGNEY 881494
MgTopA MIKNLVVIESPNKVRTLKQYLPSDE 1045802
SaTopA        MADNLVIVESPAKAKTIEKYLGKKY 14247020
RpTopA     MKLVIVESPAKAKTINKYLQDEF 6686044
SaRevG    ALQKVKTVLLVVESPNKARTISSFFSRPS 152943
MkRevG    TGRLARSALMIVESPNKARMIASLFSQRP 1173903
AaRevG    IKDLFKTTLVIVESPNKARTIAGFFGKPQ 7446038
TmRevG    VTKGGRSLLIIVESPTKAETLSRFLGRAS 2738604
AfRevG    EFDLIKPALFIVESPTKARQISRFFGKPS 7446075
SsRevG    VHFNISTGLLIVESPTKAKTIAKMFSRPS 7484129
ApRevG    GVELVRTALLVVESPNKARTIARFFGQPS 14601344
HiTopB     MRLFIAEKPSLARAIADVLPKPH 1204694
BsTopB MSKTVVLAEKPSVGRDLARVLKCHK 2632726
SaTopB MKSLILAEKPSVARDIADALQINQ 13702054
StTopB     MRLVLCEKPSQGRDIAKFLGATO 6513858
PmTopB     MRLFIAEKPSLARAIADVLPKPH 12720431
VcTopB MTRLFIAEKPSLARAIADALPKPH 11387200
EcTopB     MRLFIAEKPSLARAIADVLPKPH 148026
Glu7Lys8Ser10
Figure 2. Alignment of type IA topoisomerase sequences in the region around
Ser10andLys13ofE.coliDNAtopoisomeraseI.Thebacterialandarchealtype
IA topoisomerase sequences are divided into three groups. Topoisomerase I
(TopA), Reverse gyrase (RevG) and topoisomerase III (TopB) sequences are
from Ec (E.coli), Hi (Haemophilus influenza), Aa (Aquifex aeolicus), Tm
(Thermatoga maritima), Mg (Mycoplasma genitalium), Sa (Staphylococcus
aureus), Rp (Rickettsia prowazekii), Mk (Methanopyrus kandleri),
Af(Archaeoglobusfulgidus),Ss(Sulfolobusshibatae),Ap(Aeropyrumpernix),
Bs (Bacillus subtilis), St (Salmonella typhi), Pm (Pasteurella multocida), Vc
(Vibrio cholerae).
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somerase I mutants were created with the QuikChange site-
directed mutagenesis kit from Stratagene using plasmid
pJW312 (20) as template. The sequence of the top strand
oligonucleotides (custom synthesized by Genosys) for muta-
tions at the underlined positions were 50-CTTGTCATCGTT-
GAGCGCCCGGCAAAAG-30 (S10A), 50-GAGTCCCCGG-
CAGCAGCCAAAACGATC-30 (K13A), 50-CTTGTCATCG-
TTGAGACCCCGGCAAAAG-30 (S10T),50-GAGTCCCCGG-
CACGAGCCAAAACGATC-30 (K13R). Clones encoding the
desired mutants were identiﬁed by DNA sequencing of the
N-terminal region of the topA sequence on the plasmid. The
mutant enzymes were expressed in E.coli AS17 (topA
ts)
(20,21). Transformants were ﬁrst grown to exponential
phase at 30 C, before induction of the lacUV promoter in
pJW312 by IPTG at 42 C (19,20). The mutant enzymes
were puriﬁed with procedures similar to those used for the
wild-type E.coli topoisomerase I. The ﬁnal mutant enzyme
preparations are >95% pure as determined by Coomassie
blue staining of SDS gel after PAGE (data not shown).
Relaxation activity assay
Wild-type and mutant topoisomerases of the same concentra-
tion were diluted serially and assayed for relaxation activity in
a standard reaction volume of 20 ml with 10 mM Tris–HCl,
pH 8.0, 50 mM NaCl, 0.1 mg/ml gelatin, 6 mM MgCl2 and
0.5 mg of supercoiled pJW312 plasmid DNA (puriﬁed by CsCl
gradient centrifugation). After incubation at 37 C for 30 min.,
the reactions were stopped by adding 5 ml of 50 mM EDTA,
50% glycerol and 0.5%(v/v) bromophenol blue. The DNA was
electrophoresed in a 0.8% (w/v) agarose gel with TAE buffer
(40 mM Tris–acetate, pH 8.1 and 2 mM EDTA). The gel
was stained with ethidium bromide and photographed over
UV light.
Cleavage of 50-labeled ssDNA
An oligonucleotide with phage l DNA sequence 50-
CTCTGGCGGTGATAAATGGTT-30 was labeled at the 50
end with [g-
32P]ATP and T4 polynucleotide kinase. It was
then used as the forward primer in a PCR with l DNA as
template and a reverse oligonucleotide primer of the sequence
50-CTCTTCCGCATAAACGCTT-30, so that a 202 bp frag-
ment was generated as PCR product by Taq DNA polymerase.
Gel puriﬁcation was carried out with the GenElute spin col-
umn (Sigma). After ethanol precipitation, this DNA fragment
labeled on the 50 end of one strand was resuspended in 10 mM
Tris–HCl, pH 8.0 and 1 mM EDTA, denatured to single-
strands and incubated with the wild type and mutant enzymes
at 37 C for 10 min. After trapping the covalent complex and
cleavage of DNA by alkaline treatment (22), the DNA was
ethanol precipitated and analyzed by electrophoresis in an 8%
sequencing gel. The 50 end-labeled DNA cleavage products
were visualized with the PhosphoImager Storm 760. The yield
of the cleavage products was analyzed by the PhosphoImager
software.
Gel mobility shift assay
The 39 base oligonucleotide 50-GTTATGCAATGCGCTTT-
GGGCAAACCAAGAGAGCATAAC-30 (PAGE puriﬁed
from Genosys) with a strong topoisomerase I cleavage site
(22) was labeled at the 50 end with T4 polynucleotide kinase
and [g-
32P]ATP. The reaction mixture (10 ml) contained
20 mM Tris–HCl, pH 7.5, 100 mg/ml BSA, 12% glycerol,
1 pmol of the labeled 39mer and 0.8–8 pmol of wild type
or mutant topoisomerase I. After incubation at 37 C for
5 min, the formation of gel mobility shift complex was meas-
ured by electrophoresis in a 6% polyacrylamide gel at 4 C
with0.5·Tris–borate–EDTAbufferandanalyzedasdescribed
previously (10).
Oligonucleotide cleavage assay
The 50 end-labeled oligonucleotide used in the gel mobility
shift assay (5 pmol in 30 ml of 10 mM Tris–HCl, pH 8.0 and
1 mM EDTA) was incubated with the wild-type or mutant
enzyme at 37 C. At different time points, 3 ml aliquots of the
reaction mixture were mixed with equal volume of stop solu-
tion (79% formamide, 0.2 M NaOH and 0.04% bromophenol
blue). The mixtures were heated at 80 C for 5 min before
analysis by electrophoresis in a 15% sequencing gel. The
fraction of cleaved oligonucleotide was determined by Phos-
phoImager Storm 760 analysis.
Limited Glu-C proteolytic digestion
Wild-type and mutant topoisomerase I proteins (15 mg) in
20 mM potassium phosphate, pH 7.5, 0.1 M KCl, 0.2 mM
DTT were digested with sequencing grade Glu-C endopro-
teinase (from Roche Molecular Biochemicals) at 100:1 ratio
at 37 C for the indicated length of time. The limited proteo-
lysis was stopped by addition of equal volume of 2· gel load-
ing buffer for the Laemmli SDS gel (23) and immersion in
boiling water for 2 min. The digested samples were analyzed
by electrophoresis in a 5–20% gradient SDS polyacrylamide
gel followed by staining with Coomassie blue.
Molecular modeling
Models of the ‘open’ form of E.coli topoisomerase I com-
plexed with ssDNA were constructed from crystallographic
structures of the ‘closed’ form of E.coli topoisomerase I
[1CY0] (13), the closed form of E.coli topoisomerase III com-
plexed with ssDNA octamer [1I7D] (17), and the ‘open’ form
of the isolated topoI domains II and III [1CYY] (24). The
backbone atoms of alpha-helices in domains I, III and IV
that are homologous between 1CYO and 1I7D were used to
structurally position the ssDNA octamer in the model using
Insight II (Accelrys). The ssDNA octamer (50-CGCAACTT-
30) placed in the 1CY0 model was extended by 16 nt in a
B-DNA conformation to form a 24mer (50-CGCAACTTCA-
TCAGTCTGCGCAGT-30) since the octamer had been
observed to be in a structure similar to B-DNA (17). The
‘open’ form of domains II and III was superimposed on the
model using residues 218–225 and 468–472. Thus, the ‘open’
form model of topoisomerase I consists of 1CY0 residues
2–217 and 473–596, 1CYY residues 218–472, and a
ssDNA based on the octamer from 1I7D. Four mutations
(S10A, S10T, K13A, K13R) were introduced into the
model of the wild-type enzyme using the Biopolymer module
of Insight II,preservingthe existing side chain dihedral angles.
The ‘open’ form models for the wild type and each mutant
enzyme were transported into VMD (25) using the psfgen
utility of NAMD (26). The solvate script of VMD was used
Nucleic Acids Research, 2006, Vol. 34, No. 6 1787to place a cube of water around the ‘open’ form model stretch-
ing a minimum of 10 s beyond the protein on all sides. A
Poisson-Boltzmann calculation using APBS (27) with a coarse
grid size of 225 · 193 · 257 with grid points located  1.0 s
and a ﬁne grid size of 112 · 96 · 128 with grid points located
0.5 s was used to identify the location of electrostatic minima
with water molecules around the ‘open’ form model. In order
to generate electrostatically neutral simulation cells with an
ionic strength of 150 mM, water molecules located at the
electrostatic minima were replaced with 70 potassium,
4 sodium and 50 chloride ions such that all ions were at
least 9 s from each other; note that the K13A mutation
had 71 potassium ions due to the replacement of a cationic
residue with a neutral residue.
The CHARMM 27 force ﬁeld (28,29) was used for all
minimizations and molecular dynamic simulations. A cutoff
of non-bonded and electrostatic interactions at 12 s and
switching between 10 and 12 s was used. The simulation
cells were minimized with NAMD in three steps. First,
the residues immediately adjoining breaks formed from the
construction of the ‘open’ form model were minimized for
1000 cycles without permitting any other atomic positions
to move. Second, the water and ions were minimized for
100000 cycles without permitting motion in the topoi-
somerase complex. In the third minimization of 100000
cycles, the entire system was permitted to move.
The ﬁnal minimized structures were used as the starting
points for molecular dynamics simulations. Non-bonded
interactions were computed using the same parameters as
for energy minimizations. Electrostatic interactions were com-
puted using the particle-mesh Ewald algorithm with a cubic
spline, a tolerance of 10
 6, and a charge grid spacing of
 1.5 s. Water geometries (using a TIP3P water model)
were held rigid using the SHAKE algorithm. Each system
was heated to 300 K over 60 ps using a time step of 1 fs;
the initial heating phase was continued for another 10 ps for a
total of 70 ps. Each system was equilibrated for 200 ps, and
the production run was continued for an additional 2 ns. Data
were collected at 5 ps intervals, and analyzed using VMD
and the numerical computation package Octave (30).
Estimation of ionization and solvation energies. Estimates of
the ionization energy due to solvation and electrostatic effects
of the protonated forms of selected residues were made using
the psfgen utility of NAMD (26) and APBS (27). In this pro-
cedure, the average structures of topoIA were modiﬁed using
psfgen by replacing only one residue at a time with an altered
form of the residue: either Asp111, Asp113 or Glu115. Four
altered forms of the residues were prepared using slightly
altered patches modeled on the CHARMM 27 force ﬁeld topo-
logy ﬁles (28,29): two forms were protonated on either oxygen
of the carboxylate to model protonated aspartates/glutamates,
while two forms placed a neutral hydrogen on either carbo-
xylate oxygen to model the charged aspartates/glutamates.
These neutral hydrogens are used to maintain identical reen-
trant molecular surfaces between the protonated and charged
forms of the affected residues and were modeled to avoid
altering the electrostatic partial charges indicated for aspart-
ate/glutamate. APBS was used to calculate a thermodynamic
cycle linking topoisomerase protonated on one residue, topoi-
somerase with a neutral hydrogen on the same residue, and an
isolated hydrogen located at the same position as the titrating
proton. The Poisson–Boltzmann calculation using APBS used
coarse grid sizes of 159 · 141 · 165 with grid points located
 0.72 s and a ﬁne grid size of 113 · 103 · 117 with grid
points located  0.51 s, an ionic strength of 150 mM divided
equally between cations/anions. Calculations were either per-
formed in bulk solvent (with a dielectric of 78.54) or in
vacuum (with a dielectric of 2) to estimate the solvation
energy. The ionization energy for the ith residue [EI(i)] is
calculated as follows:
EIðiÞ¼ð Etopo1A þ EprotonÞ Etopo1AH
¼ð E
Topo1Asolvent
i   E
Topo1Avacuum
i Þ
þð EProtonsolvent   EProtonvacuumÞ
 ðE
Topo1Asolvent
iH   E
Topo1Avacuum
iH Þ:
Energies calculated for either form of a protonated aspartate
or glutamate were averaged. This protocol has been demon-
strated to reproduce the standard ionization energy test case
of the mono-carboxylate acetic acid within an error of 0.7%.
RESULTS
Mutations in Ser10 and Lys13 result in reduction of
DNA relaxation activity
To investigate the potential catalytic role of the serine and
lysine residue conserved in the active site region of bacterial
topoisomerase I, Ser10 and Lys13 of E.coli DNA topoi-
somerase I were mutated to alanines. The resulting mutant
enzymes were expressed and puriﬁed to near homogeneity
for biochemical characterization. Assays using negatively
supercoiled plasmid as substrate demonstrated that the result-
ing S10A mutant enzyme had 5- to 10-fold and K13A mutant
enzyme had around 50- to 100-fold reduction in relaxation
activity under the standard assay conditions (Figure 3A). To
determine if changing Ser10 to a threonine residue, which also
has a hydroxyl group in the side chain, and changing Lys13 to
another basic amino acid arginine allowed retention of activ-
ity, mutants S10T and K13R were constructed and puriﬁed.
Relaxation activity assays showed that introduction of a dif-
ferent side chain with similar functionality but different steric
properties at these two positions resulted in even lower relaxa-
tionactivityforthe enzyme (Figure 3B).Thein vivo activityof
these mutant enzymes was measured by their ability to com-
plement the topA mutation in strain AS17 for growth at the
non-permissive temperature of 42 C (20,21). The results
(Table 1) showed that mutations at Ser10 and Lys13 greatly
reduced the ability of topoisomerase I to support growth of the
E.coli cells, as expected from the loss of relaxation activity.
The S10A and K13A mutants were not affected in
non-covalent DNA binding
The ﬁrst step in relaxation of negatively supercoiled DNA is
the non-covalent binding of DNA with a single-strand region.
The formation of a gel mobility shift complex with a 50 labeled
oligonucleotide was assayed for the wild-type and mutant
enzymes. This oligonucleotide had a strong topoisomerase I
cleavage site (22) and was designed to form a stem–loop
1788 Nucleic Acids Research, 2006, Vol. 34, No. 6structure (Figure 4) to place the cleavage site at the junction of
ssDNA and double-stranded DNA so binding of the
oligonucleotide at the enzyme active site should be favored.
The structure of the substrate allowed the 50 end label to stay
bound in the enzyme complex under the non-denaturing gel
condition even if the initial complex has been converted to
a cleaved complex. Therefore the gel shift complex can be
evaluated as representative of the initial non-covalent com-
plex. The fraction of the initial complex converted to cleaved
complex was quantiﬁed separately by denaturing gel as
described below. The results of the gel mobility shift assay
(Figure 4) showed that the S10A and K13A mutants had DNA
binding afﬁnity similar to that of the wild-type enzyme, while
the S10T and K13R mutants had reduced DNA binding afﬁn-
ity. A lower amount of oligonucleotide–enzyme complex was
seen at saturation for the S10T and K13R mutants. The non-
covalent complexes formed by these two mutants may be
signiﬁcantly less stable during gel electrophoresis when com-
pared to the complexes formed by the wild-type and S10A and
K13A mutant enzymes. The results of the S10A and K13A
mutants showed that the loss of side chain functions at Ser10
and Lys13 affected the relaxation activity after initial binding
of the DNA substrate, because these two mutants were normal
in the formation of non-covalent complex with DNA.
ThesidechainsofSer10andLys13arerequiredforDNA
cleavage activity
The ability of the mutant enzymes to cleave a single-strand of
DNA was compared with that of the wild-type enzyme using
50-labeled ssDNA of 202 bases in length. The transient cleaved
complex represents a smaller percentage of the enzyme–DNA
complex and can be trapped by the addition of alkaline to
denature the enzyme (31). Quantiﬁcation of the results
(Figure 5) showed that the amount of transient DNA cleavage
products trapped for these mutant enzymes were 6% or less of
Figure 3. Comparison of the relaxation activity of wild-type topoisomerase I
and mutant enzymes with substitutions at Ser10 and Lys13. (A) Serial dilution
oftheWT(wild-type)andS10AandK13AtopoisomeraseI.(B)Serialdilution
of the WT (wild-type) and S10Tand K13R topoisomerase I. C, control with no
enzyme added.
Table 1. Test of in vivo complementation by the plasmid encoded
topoisomerase I mutants
Plasmid encoded topoisomerase I In vivo complementation
Wild-type 1.0
S10A 10
 3
K13A 10
 4
S10T 10
 4
K13R 10
 4
None <10
 4
Plasmid pJW312 encoding either wild type or mutant topoisomerase I was
transformedintoAS17containingapMK16lacIqplasmid(20).Serialdilutions
of cultures of the transformants (grown overnight at 30 C) were plated on
Luria–Bertani plates with ampicillin and incubated at both 42 and 30 C.
After 18–36 h incubation, the ratio of viable colonies obtained at 42 C versus
30 C is determined.
Figure 4. Effect of the mutations on the formation of the initial non-covalent
complex as assayed by the gel mobility shift assay using a 50 end-labeled
oligonucleotide.
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cleaved DNA complex which precedes DNA strand passage in
the enzyme mechanism would account for the loss of relaxa-
tion activity for these mutants.
The cleavage activity of the S10A mutant was also assessed
with the same oligonucleotide substrate used in the non-
covalent DNA-binding assay. After alkaline treatment and
under denaturing gel electrophoresis conditions, the cleaved
DNA with the 50 end-labeled dissociated from the covalent
enzyme-DNA adduct and was quantiﬁed as the fraction of
input DNA converted into the reduced size fragment. With
the wild-type topoisomerase I, the maximal yield of cleaved
DNA was reached before 20 min of the incubation for all the
enzyme:substrate ratios tested. The maximal yield of cleaved
complex at each enzyme:substrate ratio tested correlates with
the amount of enzyme present since for each cleaved DNA
molecule formed, one enzyme molecule was covalently bound
to the other half of the input substrate (Figure 6). With the
S10A enzyme, the yield of the cleaved complex observed was
 30-fold lower than the wild-type enzyme at each enzyme:
substrate ratio even after 60 min of incubation. This is con-
sistent with the interactions between the enzyme and the sub-
strate at the active site being affected by the mutation,
resulting in reduction of the cleavage activity, even though
the initial complex was formed at the same level as the
wild-type enzyme. The rates of cleavage by the other mutants
were too low to be analyzed.
TheS10TandK13Rmutantsdonothaveseverechanges
in protein folding
The S10T and K13R mutants were found to have reduced
non-covalent DNA-binding afﬁnities that could be due to
defects in protein folding arising from the introduction of
the more bulky side chains by the mutations. To determine
if these two mutants had severe changes in protein folding
compared with the wild-type topoisomerase I, limited proteo-
lysis was carried out for different lengths of time with Glu-C
endoproteinase and the products were analyzed by
SDS–PAGE. The results (Figure 7) showed that these two
mutants had the same protease digestion products proﬁle as
the wild-type topoisomerase I. Therefore it is unlikely that
these mutations have caused severe changes in the folding
of the enzyme molecule.
Molecular modeling of the active site of E.coli DNA
topoisomerase I
The molecular dynamics simulations do not capture
large-scale deviations in either domain 1 or 4 that alter the
topoisomerase I conformation from the crystal structure: the
average structures of domain 1 and the 8 nt bound to this
domain remain within an root mean square deviation
Figure 5. DNAcleavageactivityofthewild-typeandmutantenzymes.ssDNA
labeled at the 50 end was used as substrate for analysis of the cleavage activity
using400ngofWT(wild-type)andmutantenzymes.C,controlwithnoenzyme
added.
Figure 6. Time course of oligonucleotide cleavage by wild-type and S10A
mutanttopoisomerasesatdifferentenzyme:substrateratios.Eachreactioncon-
tained 5 pmol of 50-labeled oligonucleotide substrate. Results are from the
average of three experiments.
1790 Nucleic Acids Research, 2006, Vol. 34, No. 6(r.m.s.d.)of1.8 s,while the average structures ofdomains1, 4
and the nucleotides remain withinan r.m.s.d. of 2.8 s (data not
shown).
The observed large-scale motion in domains 2 and 3 in the
mutatedenzymes may drive theincreasingr.m.s.d.observedin
domain 4, owing to the connections and proximity of these
domains. However, the limited scale of the 2 ns simulations
does not allow us to sample a sufﬁciently large ensemble to
make a statistically signiﬁcant determination of correlated
motions in the topoisomerase domains. In the wild-type simu-
lation, we note that these motions initiate closing of the open
form complex by bringing domains 1 and 3 closer by  10 s
(data not shown). Helix O (residues 496–507) also moves to
clamp down over the DNA in the complex (Figure 8); the
motion of this helix appears to occur as a result of DNA
occupancy of the active site and the closing motion of the
WT enzyme, as suggested by Perry and Mondrago ´n (18).
We note that the enzyme closes rapidly during the simulations,
with the distance between domains 1 and 3 closing by 20 s
within 10 ns (data not shown).
In the wild-type complex, Lys13 interacts with Glu9 and
Asp111, mirroring the interactions observed in the closed
co-crystal complexes (17,18); however the Lys13 NZ group
more closely follows the geometry observed in the closed
enzyme without DNA (13) and is  7 s from the scissile
phosphate (Table 2 and Figure 9D). Ser10 forms a direct
hydrogen bond with phosphate 8, adjacent to the scissile nuc-
leotide at position 7 (Figure 9A). This interaction between
Ser10 and the DNA is slightly different from the crystal struc-
ture of the topo III closed complex (17), where this residue
makes an analogous water-mediated contact to the terminal
phosphate of the octamer. These differences may be due to the
difference between the ‘open’ and ‘closed’ conformations of
the enzyme, or the presence of 16 additional nucleotides bey-
ond the crystallographic octamer.
The two mutations of Ser10 have different effects on
the active site structure. In the S10A topoisomerase I
mutant, Ala10 is unable to form a hydrogen bond with
phosphate 8 (Figure 9B). This absence of this interaction
increases the ﬂexibility of Ala10 and Lys13, perturbing the
interactionsbetweenLys13,Asp111andthescissilephosphate
(Table 2).
Intriguingly, the loss of the hydroxyl interaction with phos-
phate 8 results in a small rotation of the phosphate 8 group; the
rotation is towards the neutral alanine side chain, presumably
due to the attractive forces of the nearby backbone nitrogens
and the K13 side chain. This rotation may force the 7 deox-
yribose (adjacent to the scissile phosphate) to move rigidly
without altering the deoxyribose’s conformation (Table 3),
possibly due to the surface constraints underneath the ribose
provided by Glu9, Val31 and Gly32.
Figure 7. Limited proteolysis by Glu-C endoproteinase. The time course of digestion of wild-type topoisomerase I by Glu-C endoproteinase is compared with the
S10T and K13R mutant enzymes.
Figure 8. Movement of helix O in the WT complex. The crystal structure of
E.colitopoisomeraseI[1CY0,(13)]isshowninblue;helixOof1CYOisshown
in black. The average structure of the wild-type topoisomerase I from the final
1.34 ns of the simulation is shown in green; helix O of the wild-type enzyme is
shown in red. The ssDNA substrate in the wild-type simulation is shown in
orange.
Nucleic Acids Research, 2006, Vol. 34, No. 6 1791Figure 9. EffectsofmutationsonsimulatedmodelsoftopoisomeraseI.(A–C)MutationsofS10.(D–F)MutationsofK13. (A) wild-typeenzyme.(B) S10Amutant
enzyme.(C)S10Tmutantenzyme.(D)Wild-typeenzyme.(E)K13Amutantenzyme.(F)K13Rmutantenzyme.Eachstructureisaminimizedaveragestructurefrom
approximately the final 1.2 ns of each simulation, superimposed using the backbone atoms of domains I and IV.
Table 2. Interaction distances of residues 10 and 13 in wild-type and mutant topoisomerases
Mutant S10:OG-8:O1P S10:CB-K13:CB K13:NZ-E9:OE1/2 K13:NZ-D111:OD1/2 K13:NZ-Thy7:P
WT 2.7 ± 0.2 3.7 ± 0.2 2.8 ± 0.2 3.1 ± 0.3 6.9 ± 0.4
S10A 3.6 ± 0.2* 4.2 ± 0.5 2.7 ± 0.1 4.6 ± 1.1 8.5 ± 1.0
S10T 3.8 ± 0.2 5.0 ± 0.2 2.7 ± 0.2 3.2 ± 0.5 7.3 ± 0.5
K13A 2.7 ± 0.4 4.7 ± 1.0 6.2 ± 0.9* 6.8 ± 0.7* 10.1 ± 0.8*
K13R 2.7 ± 0.2 4.0 ± 0.3 3.9 ± 0.2* 5.9 ± 1.3* 9.7 ± 1.1*
Interactiondistancesaregiveninangstromsasthemeanover400structuressampledatafrequencyof5ps;theSDofeachdistanceisindicated.ForresiduesGlu-9,the
reported distance is the average of the two distances measured between residue 13 and Glu9:OE1 and between residue 13 and Glu9:OE2; similarly, the computed
distances for Asp111 are also the average of two distances. For the three mutants S10A, K13A and K13R, certain interactions (indicated by asterisks) could not be
calculatedduetoatomsnotpresentinthestructures;ineachcase,alternativeatomswerechosen.FortheS10Amutant,theatomCBwassubstitutedforOG.Forthe
K13A mutant, the atom CB was substituted for NZ. For the K13R mutant, the atoms NH1 and NH2 were substituted for NZ.
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larger force to the scissile phosphate and the 6 deoxyribose.
The zeta backbone dihedral angle just past the scissile
phosphate (running from 7:O50–7:P–6:O30–6 C30) changes
from a  60-synclinal conformation in the WT to a  130-
antiplanar conformation in the S10A mutant. The rotation
of this backbone dihedral alters the deoxyribose conformation
of residues 6 and 5, forcing them from a c30-endo ‘northern’
pucker to a c20-endo ‘southern’ pucker conformation. These
altered sugar conformations have two effects: the remaining
path of the DNA substrate (towards deoxyribose 1) rotates to
followthe riboses andthe6deoxyribosestericallyclasheswith
Glu115 (Figure 10). In the wild-type enzyme, the C30 atom of
the 6 deoxyribose is 6.3 s from Glu115 CB, but this has
shortened to 3.9 s in the S10A mutant. Owing to the steric
clash, Glu115 rotates towards Asp113 and Asp111, altering
the conformation ofthe catalytictriad observedinthe enzymes
that retain a hydroxyl at residue 10.
The combined effect of this novel conformation of the cata-
lytic triad enhances the local electrostatics (Figure 11A) and
may interfere with magnesium binding. We note that isolated
carboxylatespossesspKa’sthattypicallyrangenear4.1,butthe
close proximity of the carboxylates of the catalytic triad in the
S10Amutant isexpectedtosubstantiallyraise one ormorepKa
values (owing to collective inﬂuence of the individual anion’s
electrostatic ﬁeld). When the pH dependence of the S10A mut-
ant was compared with that of the wild-type topoisomerase
(Figure 11B), it was observed that while the wild-type enzyme
was active at pH 5.5, the S10A mutant required pH to be
elevatedto6.0forrelaxationactivitytobeobserved,suggesting
a protonation event between pH 5.5–6.0 in the S10A mutant to
inﬂuence the activity. Calculations of the solvation and elec-
trostatic energies stabilizing the protonated forms of Asp111
and Asp113 in the S10A enzyme show that both residues are
Table 3. Deoxyribose conformations in WT and S10A complexes
Deoxyribose WT S10A
Thy 8 160.0 c20 endo 160.8 c20 endo
Thy 7 16.0 c30 endo 20.0 c30 endo
Cyt 6 9.5 c30 endo 145.3 c10 exo c20 endo
Ade 5 15.8 c30 endo 170.4 c20 endo
Ade 4 155.1 c20 endo 166.0 c20 endo
Pseudorotation phaseangles(inunitsofdegrees)are sampledfromthe average
structure from approximately the last 1 ns of the simulation.
Figure 10. Conformationalchanges due to loss ofthe S10hydroxyl.(A) Wild-typeenzyme.(B) K13A mutantenzyme.(C) S10A mutantenzyme.Left, side views,
illustratingthe conformationalchangesin theDNAsubstratebackbone.Baseshavebeenomittedforclarity.Right,topview,lookingdownontheacidicresiduesin
the active site. Each structure is a minimized average structure from approximately the final 1.2 ns of each simulation, superimposed using the backbone atoms of
domains I and IV.
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ates than in the wild-type enzyme. The protonated form of
Asp111 in the S10A mutant is stabilized by an average energy
difference of  8.9 kJ/mol over the protonated Asp111 in the
wild-type enzyme, corresponding closely to a pKa increase of
 1.55 U. Compared with the model compound of an isolated
carboxylate with a pKanear 4.1, this raises the pKapredictedof
Asp111 in the S10A enzyme to  5.7 (neglecting energies due
to conformational adjustments). We note that the Asp111 is an
invariant residue in TOPRIM domains and is expected to par-
ticipate in magnesium binding; protonation of this residue
would interfere with the magnesium ion and DNA cleavage.
The close correspondence between the computed DNA con-
formations and novel catalytic triad conformation and the
experimental pH shift of the S10A enzyme strongly suggests
the validity of the structures sampled during the computational
simulations. The residual activity that remains in the S10A
mutant(Table1)alsosuggeststhataminorsubsetofconforma-
tions may exist in which the DNA substrate resembles the
wild-type complex; however, such structures corresponding
toactive(i.e.wild-type)formswerenotobservedinthislimited
modeling of the S10A mutant and may be observed during
longer duration simulations.
In the S10T mutant, Thr10 forms a hydrogen bond with
phosphate 8 (Figure 9C); however, this interaction is longer
thantheSer10interaction,indicatingitsrelativeweakness.The
CG2 methyl group ofThr10 pushes against the alkylside chain
ofLys13;thus,Thr10alsoincreasesthedistancebetweenThy8
and Lys13 and increases the motion of Lys13 relative to the
wild-typecomplex(Table2).ThiscollisionbetweenThr10and
Lys13alsoforcesThr10tomoveawayfromtheclash;however,
Glu9 is adjacent to Thr10 and also moves backwards. In the
wild-type complex, the distance between the Glu9 CD and the
Asp113 CG is 10.7 s; in the S10T mutant, this distance
increases to 11.7 s. The increase of this distance suggests
that the S10T mutation may force Glu9 into a geometry
where it may be unable to interact within the catalytic triad
and the magnesium ion possibly coordinated at this site.
Although Ala13 in the K13A mutant is unable to make
interactions with the acidic residues of the active site, no
other distortions occur to the residues Glu9, Asp111,
Asp113 and Glu115 (Figure 9E). The decreased activity
Figure 11. Surface potential map and alteration of pH profile for wild-type and S10A mutant topoisomerases. (A) Top left, wild-type enzyme. Bottom left, S10A
mutant.Theelectrostaticpotential,mappedonthemolecularsurfaceconstructedusingMSMS(38),wascomputedusingAPBS(27)tofocusontheactivesitewitha
finalgridspacingof 0.5s.Eachstructureisaminimizedaveragestructurefromapproximatelythefinal1.2nsofeachsimulation,superimposedusingthebackbone
atomsofdomainsIandIV.(B)TheeffectofreactionpHontherelaxationactivityofwild-type(topright)andS10Amutant(bottomright)enzymes.ThereactionpH
wasmaintainedwith36mMMesforpH5.0–6.5,TrisforpH7.0–8.5,ChesforpH9.0–10.0.Theenzyme(400ng)wasfirstequilibratedwithbufferoftheindicatedpH
beforeadditionofsupercoiledplasmidDNAand8mMMgCl2.Thefinalreactionmixture(13mltotal volume)wasincubatedat37 C for30min.C, controlwithno
enzyme added.
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may play a role in the catalytic site, perhaps as a polarizing
inﬂuence on Glu9. However, additional investigation of the
active site is required to evaluate this hypothesis.
The Arg13 residue in the K13R topoisomerase I mutant is a
larger residue than lysine, and is unable to ﬁt in the space
assigned to Lys13 and accommodate the interactions with both
Glu9 and Asp111. Arg13 continues to interact with Glu9,
owing to the favorable electrostatics but these interactions
become distorted due to the size of Arg13 (Figure 9F).
Arg13’s guanidinium moiety pushes against Glu9, altering
the conformation of Glu9. Asp111 rotates out of the acidic
pocket due to Glu9’s motion, and Asp111’s motion pushes
Glu115 and Asp113; in essence, Arg13’s intrusion into the
acidic pocket forces a ‘domino effect’ where all the acidic
residues shift their conformation. Glu9 also pushes on the
Arg13 guanidinium group, forcing the Arg13 backbone to
move away by  1 s. This motion shifts the entire backbone
in this region (including Ser10) by  1 s; in turn, the path of
the ssDNA shifts to follow these interactions. The distorted
active site of the K13R mutant is apparently catalytically
incompetent due to the severe steric clashes.
DISCUSSION
The multi-step process of change of linking number catalyzed
by topoisomerases is likely to require participation of different
functional groups in different steps of the reaction. In the
current mechanism of E.coli topoisomerase I, Tyr319 is
responsible for nucleophilic attack on DNA and formation
of the covalent bond between the enzyme and the 50 phosphate
of the cleaved DNA (7). Glu9 found also in the active site has
been implicated in the process of DNA cleavage (9,10). In its
proximity, Ser10 and Lys13 are conserved residues with side
chains that could also participate in the catalytic process.
Results presented here on the site-directed mutants support
a role for these two residues in the DNA cleavage step of
the enzyme mechanism. Altering these residues to alanines
did not affect non-covalent binding to DNA, but signiﬁcantly
reduced the formation of the cleaved DNA complex. The
changes of Ser10 to Thr and Lys13 to Arg had more severe
effects on the enzyme, reducing also the non-covalent binding
of enzyme to DNA. Although proteolytic digestion of the
S10T and K13R mutants did not indicate severe defects in
protein folding, the changes in the side chains in these sub-
stitutions could potentially affect the structure of the junction
region between domains I and III at the active site, affecting
also the non-covalent interaction of the enzyme with the
single-strand of DNA that has to be positioned at the active
site for cleavage.
In the crystal structure of E.coli topoisomerase III com-
plexed with ssDNA (17), the lysine residue (Lys8) that cor-
respondsto Lys13 in topoisomerase I isin a position to interact
with the phosphate group of the scissile bond (Figure 1). The
importance of this residue in DNA cleavage as suggested by
the structural data (17) is now demonstrated biochemically in
this study.
In the structure of the 67 kDa N-terminal fragment of topoi-
somerase I, the side chains of both Ser10 and Lys13 are in
the vicinity of Tyr319 with their relative positions switched
when compared with Lys8 and Ser10 of topoisomerase III
(Figure 1). The positively charged side chain of Lys13 is
expected to interact with either the scissile phosphate and/
or the acidic pocket of Glu9/Asp111/Asp113 via electrostatic
interactions. The results from our molecular modeling simu-
lations support the interaction of Lys13 with the acidic pocket,
particularlywithGlu9andAsp111.Althoughourmodelsshow
that the distance from Lys13’s amide group to the scissile
phosphate is  7 s, conformational changes in the enzyme
might easily halve the distance between these groups. Mod-
eling studies currently underway simulating the transition of
the ‘open’ complex to the ‘closed’ complex may reveal further
details of these proposed interactions.
In the crystal structure of the topoisomerase III–DNA com-
plex (17), the side chain of Ser10 does not appear to be in a
positionto participatedirectly inDNA cleavage. Nevertheless,
this residue is in proximity to the phosphate immediately 30 of
the scissile phosphate and a water-mediated hydrogen bond is
observed between Ser10 and this phosphate. The topoi-
somerase enzyme used in the crystallization of this complex
has phenylalanine substituted for the active site tyrosine. It is
also in the absence of the Mg
2+ ions required for catalytic
activity and using a short oligonucleotide substrate. It cannot
be ruled out that with the conformational changes expected
from topoisomerase in the presence of either an active site
tyrosine, Mg
2+ ions, or with longer ssDNA substrates that the
position of the side chain of this serine residue could change to
participate more directly in DNA cleavage. In our simulated
topoisomerase I complex with a longer oligonucleotide, the
side chain of Ser10 forms a hydrogen bond directly with
the phosphate 30-adjacent to the scissile phosphate. This inter-
action appears to be crucial to the positioning of the DNA
substrate in the active site; when this hydroxyl was removed in
the S10A mutant, deoxyribose 6 located 50 to the scissile
phosphate shifted from a ‘northern’ pucker to the ‘southern’
pucker typical of B-form DNA. In the F328Y topo-III and
H365R topo-I cocrystals (17,18), the analogous deoxyriboses
are also observed in a ‘northern’ pucker conformation. The
‘northern’ ribose conformations uniquely position O30 along
the equitorial plane of the ribose which orients the adjacent
phosphate oxygens towards the tyrosine nucleophile. Thus,
Ser-10 aides the positioning of the scissile phosphate for
DNA cleavage and may account for the conserved presence
of this serine residue among type IA topoisomerase sequences.
We propose that helix O and Ser10, respectively are the 50 and
30 ends of a clamp that holds the DNA substrate in the active
site properly positioned for cleavage.
Topoisomerase mechanisms share a common feature with
some enzymatic phosphoryl transfer reactions in the formation
of a covalent intermediate. In these two-stage mechanisms, an
enzyme nucleophile ﬁrst attacks a phosphorus to form a stable
covalent intermediate. In the second stage of the reaction, the
covalent intermediate is in turn attacked by a nucleophile to
generate the free enzyme again and reaction products (32).
Enzymatic phosphoryl or nucleotidyl transfer reactions are
often facilitated by surrounding the attacked phosphate with
positively charged groups including the side chain of lysine
residues (33,34). In the study of the mechanism of enzymatic
phosphoryl transfer by phosphoserine phosphatase, a
hydrogen bond between an active site serine residue and a
non-bridging oxygen of the phosphoryl group, as well as
salt bridge interactions by an active site lysine residue,
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ization (32,35). Therefore examples of utilization of a com-
bination of conserved active site serine and lysine residues
to catalyze the formation of a phosphoryl-enzyme covalent
intermediate are already known.
A role for the conserved Arg321 with its positively charged
guanidinium group close to the active site tyrosine hydroxyl in
promoting nucleophilic attack by Tyr319 by stabilization of
the negatively charged phenolate ion has been proposed for
the mechanism of E.coli DNA topoisomerase I (9,13,24). The
corresponding arginine Arg330 in E.coli DNA topoisomerase
III was observed to contact the scissile phosphate in the com-
plex with ssDNA (17). A similarly positioned arginine residue
may have similar functions in type II topoisomerases (36,37).
Based on the structure of E.coli DNA topoisomerase III
complexed to ssDNA, it was also proposed that Glu7 of topoi-
somerase III (corresponding to Glu9 of E.coli DNA topoi-
somerase I) acts as a general acid catalyst by donating a
proton to the leaving 30-oxygen atom of the scissile bond
during DNA cleavage and may also act to abstract a proton
from the free 30-hydroxyl group during nucleophilic activation
for DNA religation (17). Mutagenesis studies of His365 of
E.coli DNA topoisomerase I led to the proposal that His365
donates a proton to Asp111 which then relays the charge to
Glu9 for its protonation (14). The stable salt bridge that Lys13
forms with Glu9 and the observed activity defects in alanine
mutagenesis suggests that Lys13 may participate in the proton
transfer.
This study provides biochemical evidence that contact with
the 30-downstream phosphate involving Ser10 may also be
important for the cleavage step of catalysis and that a second
positively charged side chain may be used in the active site to
donate a proton and/or contact the scissile phosphate. Similar
roles have also been suggested for other active site residues
(9,10,18). Active site residues in the topoisomerase may play
multiple roles, further underscoring the ﬁnding that few alan-
ine mutations completely eliminate relaxation activity (9).
Additionalstructuralinformationonthe different conforma-
tions of the enzyme and its complex with DNA, molecular
modeling of the different topoisomerase states and the pro-
posed catalytic mechanisms, and mutagenesis data on other
conserved amino acids with potential catalytic roles will help
elucidate the mechanism of this class of enzyme.
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